Dr. Joao A M Deandrade, MD

Dr. Deandrade practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Deandrade's NPI, 1861435745, was assigned on June 14, 2006. Dr. Deandrade graduated from Federal University of Rio Grande do Sul School of Medicine in 1990. Dr. Deandrade holds Tennessee license 58476.

Dr. Deandrade's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Deandrade's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Deandrade to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deandrade practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Deandrade's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Deandrade is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Deandrade's licenses on file in 2 states: Tennessee and Alabama.

Dmand AI lists acute respiratory failure, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, lung disease: COPD, asthma or bronchitis, pleural effusion, pneumonia and respiratory infection and pulmonary fibrosis among the conditions Dr. Deandrade treats.

CMS data shows 242 Medicare services from Dr. Deandrade across 8 procedure codes in 2024, for 133 Medicare patients. Medicare paid $16,943 for them.

CMS counts 133 Medicare patients who saw Dr. Deandrade in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deandrade's median patient age at 71, with 49% women.

In 2024, Dr. Deandrade wrote 289 Medicare Part D claims for 61 patients. 51% of them were for generic drugs. CMS names the drug for 199 of them, across 7 drugs with 11 or more claims each, at $1,047,173 in total drug cost. In 2023, CMS named 129 claims across 4 drugs.

Dr. Deandrade accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deandrade as offering telehealth.

Dmand AI links 1 paper to Dr. Deandrade. Dr. Deandrade's most frequent co-authors are Veena B. Antony, MD and Tracy Renee Luckhardt.

Dmand AI links Dr. Deandrade to 3 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis. Duke University sponsors the most, 3.

CMS Open Payments shows 467 general payments to Dr. Deandrade from 8 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $273,947. It also lists 2 research payments totaling $3,500 from 2022 to 2023.

Dmand AI lists 8 awards for Dr. Deandrade, most recently AOA in 2018.

Dr. Deandrade graduated from Federal University of Rio Grande do Sul School of Medicine in 1990.

Dr. Deandrade is in network with 11 carriers, including Cigna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.